Related Experiment Video
Updated: Jul 5, 2026
06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Latent (slowly progressing) autoimmune diabetes in adults
1Diabetes Center, Medical Clinic Innenstadt, Ludwig-Maximilians-University Munich, Ziemssenstrasse 1, München 80336, Germany. jochen.seissler@med.uni-muenchen.de
Current Diabetes Reports
|May 1, 2008
Summary
Latent autoimmune diabetes in adults (LADA) is an autoimmune diabetes subtype affecting 10% of type 2 diabetes patients. Understanding LADA immune markers is crucial for managing this condition and preventing insulin dependency.
Area of Science:
- Endocrinology
- Immunology
- Metabolic Diseases
Background:
- Latent autoimmune diabetes in adults (LADA) presents intermediate features between type 1 and type 2 diabetes.
- Approximately 10% of type 2 diabetes patients have LADA, characterized by autoimmune beta-cell destruction and insulin dependency.
Purpose of the Study:
- To review current knowledge on immune markers in LADA.
- To highlight the need for further research into LADA pathogenesis, prevention, and treatment.
Main Methods:
- Literature review of recent studies on LADA.
- Analysis of immune markers associated with beta-cell loss in LADA patients.
Main Results:
- Novel information on immune markers linked to progressive beta-cell loss in LADA has emerged.
- LADA patients show a rapid decline in residual beta-cell mass, leading to insulin dependency.
Conclusions:
- LADA pathogenesis remains poorly understood.
- Further research is essential to develop effective prevention and treatment strategies for LADA.
- Identifying specific immune markers could aid in early diagnosis and management of LADA.
Related Concept Videos
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...